Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
TAVR for moderate AS? | A ‘dramatic reduction’ in radiation exposure during EVAR | Late balloon valvuloplasty
Wednesday, May 11, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Is TAVR a sensible choice for patients with moderate, symptomatic aortic stenosis? Medtronic aims to find out

The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.

READ MORE >
TAVR Medtronic Evolut EXPAND TAVR II Pivotal Trial will study the use of T AVR in patients with moderate, symptomatic aortic stenosis.
Share on Twitter Share on Facebook Share on Linkedin

Is TAVR a sensible choice for patients with moderate, symptomatic aortic stenosis? Medtronic aims to find out

Share on Twitter Share on Facebook Share on Linkedin
TAVR Medtronic Evolut EXPAND TAVR II Pivotal Trial will study the use of T AVR in patients with moderate, symptomatic aortic stenosis.
The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.
READ MORE >

When PPE is not enough: Improved shielding during EVAR linked to ‘dramatic reduction’ in radiation exposure

“Improving ancillary shielding barriers is paramount,” according to the authors of a brand new analysis. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

When PPE is not enough: Improved shielding during EVAR linked to ‘dramatic reduction’ in radiation exposure

Share on Twitter Share on Facebook Share on Linkedin
“Improving ancillary shielding barriers is paramount,” according to the authors of a brand new analysis. 
READ MORE >

Late balloon valvuloplasty safe and effective for patients with THV dysfunction

The median time from heart valve implantation to balloon dilatation was 4.6 months.

READ MORE >
Balloon valvuloplasty months after implantation is a safe and effective treatment option for patients with transcatheter heart valve (THV) dysfunction, according to a new analysis published in the Journal of the American College of Cardiology
Share on Twitter Share on Facebook Share on Linkedin

Late balloon valvuloplasty safe and effective for patients with THV dysfunction

Share on Twitter Share on Facebook Share on Linkedin
Balloon valvuloplasty months after implantation is a safe and effective treatment option for patients with transcatheter heart valve (THV) dysfunction, according to a new analysis published in the Journal of the American College of Cardiology
The median time from heart valve implantation to balloon dilatation was 4.6 months.
READ MORE >

Featured Articles

Cardiologist charged with 4 additional counts of sexual assault after more patients come forward

The 66-year-old cardiologist was first charged with sexual assault in 2022 after a patient accused him of touching her inappropriately. Now, more patients have stepped forward with similar stories. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist charged with 4 additional counts of sexual assault after more patients come forward

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The 66-year-old cardiologist was first charged with sexual assault in 2022 after a patient accused him of touching her inappropriately. Now, more patients have stepped forward with similar stories. 
READ MORE >

Flu shots lower CVD risk, new meta-analysis confirms

The study's authors tracked data from six different randomized controlled trials, including a large study from 2021 that focused on myocardial infarction patients.

READ MORE >
Flu Shots can help lower risk factors to prevent cardiac events in a new study. Flu shots are associated with a significant reduction in the risk of cardiovascular complications or pneumonia in patients with heart failure, according to new findings published in The Lancet Global Health.
Share on Twitter Share on Facebook Share on Linkedin

Flu shots lower CVD risk, new meta-analysis confirms

Share on Twitter Share on Facebook Share on Linkedin
Flu Shots can help lower risk factors to prevent cardiac events in a new study. Flu shots are associated with a significant reduction in the risk of cardiovascular complications or pneumonia in patients with heart failure, according to new findings published in The Lancet Global Health.
The study's authors tracked data from six different randomized controlled trials, including a large study from 2021 that focused on myocardial infarction patients.
READ MORE >

VIDEO: Use of CT to assess coronary plaques

Leslee Shaw, PhD, director of The Blavatnik Family Women’s Health Research Institute, Mount Sinai Hospital, New York, explains how cardiac computed tomography (CT) can be used to assess coronary plaques.

READ MORE >
An example of CT imaging coronary plaque assessment on TeraRecon's advanced visualization software.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Use of CT to assess coronary plaques

Share on Twitter Share on Facebook Share on Linkedin
An example of CT imaging coronary plaque assessment on TeraRecon's advanced visualization software.
Leslee Shaw, PhD, director of The Blavatnik Family Women’s Health Research Institute, Mount Sinai Hospital, New York, explains how cardiac computed tomography (CT) can be used to assess coronary plaques.
READ MORE >

Links to all the SCAI 2022 late-breaking clinical research

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions. 

READ MORE >
Simpsons Interventions, a California-based healthcare technology company, has received the FDA’s breakthrough device designation for its Acolyte Image Guided Crossing and Re-Entry Catheter System. SCAI released the list of its late-breaking clinical study trials at its 2022 annual meeting. #SCAI #SCAI22 #SCAI2022
Share on Twitter Share on Facebook Share on Linkedin

Links to all the SCAI 2022 late-breaking clinical research

Share on Twitter Share on Facebook Share on Linkedin
Simpsons Interventions, a California-based healthcare technology company, has received the FDA’s breakthrough device designation for its Acolyte Image Guided Crossing and Re-Entry Catheter System. SCAI released the list of its late-breaking clinical study trials at its 2022 annual meeting. #SCAI #SCAI22 #SCAI2022
The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions. 
READ MORE >

Small wearable device monitors blood sugar, alcohol and lactate levels at the same time

Engineers detailed their prototype, which is roughly the size of a small stack of quarters, in Nature Biomedical Engineering.

READ MORE >
Engineers have developed and tested a new wearable device capable of monitoring a person’s blood sugar, alcohol and lactate levels all at the same time, detailing their work in Nature Biomedical Engineering
Share on Twitter Share on Facebook Share on Linkedin

Small wearable device monitors blood sugar, alcohol and lactate levels at the same time

Share on Twitter Share on Facebook Share on Linkedin
Engineers have developed and tested a new wearable device capable of monitoring a person’s blood sugar, alcohol and lactate levels all at the same time, detailing their work in Nature Biomedical Engineering
Engineers detailed their prototype, which is roughly the size of a small stack of quarters, in Nature Biomedical Engineering.
READ MORE >

In Other News

Pfizer to acquire Biohaven Pharmaceuticals for $11.6B

Biohaven is known as the company behind Nurtec ODT, a dual-acting migraine therapy approved for both the acute treatment and episodic prevention of migraines.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Pfizer to acquire Biohaven Pharmaceuticals for $11.6B

Share on Twitter Share on Facebook Share on Linkedin
Biohaven is known as the company behind Nurtec ODT, a dual-acting migraine therapy approved for both the acute treatment and episodic prevention of migraines.
READ MORE >

DOJ now investigating Cerebral for ADHD prescribing practices

As a result, the company stated it will pause the practice of prescribing controlled substances as a treatment for ADHD such as Adderall and Ritalin for new patients starting May 9.

READ MORE >
thumbnail_image.png
Share on Twitter Share on Facebook Share on Linkedin

DOJ now investigating Cerebral for ADHD prescribing practices

Share on Twitter Share on Facebook Share on Linkedin
thumbnail_image.png
As a result, the company stated it will pause the practice of prescribing controlled substances as a treatment for ADHD such as Adderall and Ritalin for new patients starting May 9.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme